175 related articles for article (PubMed ID: 2273487)
21. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
Fox RI; Morgan SL; Smith HT; Robbins BA; Choc MG; Baggott JE
Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
[TBL] [Abstract][Full Text] [Related]
22. Histologic changes in rheumatoid synovitis induced by naproxen and methotrexate.
Balsa A; Gamallo C; Martín-Mola E; Gijón-Baños J
J Rheumatol; 1993 Sep; 20(9):1472-7. PubMed ID: 8164201
[TBL] [Abstract][Full Text] [Related]
23. Folic acid alters methotrexate availability in patients with rheumatoid arthritis.
Bressolle F; Kinowski JM; Morel J; Pouly B; Sany J; Combe B
J Rheumatol; 2000 Sep; 27(9):2110-4. PubMed ID: 10990220
[TBL] [Abstract][Full Text] [Related]
24. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
Alsufyani K; Ortiz-Alvarez O; Cabral DA; Tucker LB; Petty RE; Malleson PN
J Rheumatol; 2004 Jan; 31(1):179-82. PubMed ID: 14705239
[TBL] [Abstract][Full Text] [Related]
25. Nonsteroidal antiinflammatory drugs in rheumatoid arthritis: duration of use as a measure of relative value.
Luggen ME; Gartside PS; Hess EV
J Rheumatol; 1989 Dec; 16(12):1565-9. PubMed ID: 2625688
[TBL] [Abstract][Full Text] [Related]
26. Clinically significant gastropathy associated with nonsteroidal antiinflammatory drug use in children with juvenile rheumatoid arthritis.
Keenan GF; Giannini EH; Athreya BH
J Rheumatol; 1995 Jun; 22(6):1149-51. PubMed ID: 7674245
[TBL] [Abstract][Full Text] [Related]
27. Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review.
Colebatch AN; Marks JL; van der Heijde DM; Edwards CJ
J Rheumatol Suppl; 2012 Sep; 90():62-73. PubMed ID: 22942332
[TBL] [Abstract][Full Text] [Related]
28. Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs.
Tugwell P; Ludwin D; Gent M; Roberts R; Bensen W; Grace E; Baker P
J Rheumatol; 1997 Jun; 24(6):1122-5. PubMed ID: 9195520
[TBL] [Abstract][Full Text] [Related]
29. Lymphocyte phenotype studies of rheumatoid arthritis patients treated with methotrexate.
Lacki JK; Mackiewicz SH; Wiktorowicz KE
Arch Immunol Ther Exp (Warsz); 1994; 42(4):287-90. PubMed ID: 7487368
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
[TBL] [Abstract][Full Text] [Related]
31. Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancer.
Sweeney CJ; Takimoto CH; Latz JE; Baker SD; Murry DJ; Krull JH; Fife K; Battiato L; Cleverly A; Chaudhary AK; Chaudhuri T; Sandler A; Mita AC; Rowinsky EK
Clin Cancer Res; 2006 Jan; 12(2):536-42. PubMed ID: 16428497
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Sinnett MJ; Groff GD; Raddatz DA; Franck WA; Bertino JS
J Rheumatol; 1989 Jun; 16(6):745-8. PubMed ID: 2674426
[TBL] [Abstract][Full Text] [Related]
33. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Anaya JM; Fabre D; Bressolle F; Bologna C; Alric R; Cocciglio M; Dropsy R; Sany J
J Rheumatol; 1994 Feb; 21(2):203-8. PubMed ID: 8182625
[TBL] [Abstract][Full Text] [Related]
34. High-dose methotrexate: pharmacokinetics in children and young adults.
Raude E; Oellerich M; Weinel P; Freund M; Schrappe M; Riehm H; Poliwoda H
Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):364-70. PubMed ID: 3209285
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
[TBL] [Abstract][Full Text] [Related]
36. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
[TBL] [Abstract][Full Text] [Related]
37. Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis.
Ortiz-Alvarez O; Morishita K; Avery G; Green J; Petty RE; Tucker LB; Malleson PN; Cabral DA
J Rheumatol; 2004 Dec; 31(12):2501-6. PubMed ID: 15570658
[TBL] [Abstract][Full Text] [Related]
38. [Drug therapy of inflammatory arthritis in children].
Prieur AM
Rev Prat; 1994 Dec; 44(19):2593-9. PubMed ID: 7855528
[TBL] [Abstract][Full Text] [Related]
39. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of the pharmacokinetics of MTX in juvenile idiopathic arthritis patients receiving long-term MTX monotherapy or MTX plus chloroquine.
Kimura E; Oga S; Pereira RM
J Clin Pharm Ther; 2007 Dec; 32(6):579-84. PubMed ID: 18021335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
